Share on StockTwits

Baxter International (NYSE:BAX) has been given an average recommendation of “Hold” by the sixteen analysts that are presently covering the company, Stock Ratings Network.com reports. Seven investment analysts have rated the stock with a hold recommendation and six have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $79.23.

Shares of Baxter International (NYSE:BAX) traded up 0.42% during mid-day trading on Wednesday, hitting $74.08. The stock had a trading volume of 733,354 shares. Baxter International has a 52-week low of $62.80 and a 52-week high of $77.31. The stock has a 50-day moving average of $75.40 and a 200-day moving average of $73.14. The company has a market cap of $40.127 billion and a P/E ratio of 20.79.

Baxter International (NYSE:BAX) last announced its earnings results on Thursday, July 17th. The company reported $1.26 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.22 by $0.04. The company had revenue of $4.30 billion for the quarter, compared to the consensus estimate of $4.12 billion. During the same quarter in the prior year, the company posted $1.16 earnings per share. The company’s quarterly revenue was up 16.2% on a year-over-year basis. On average, analysts predict that Baxter International will post $5.16 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which is scheduled for Wednesday, October 1st. Shareholders of record on Friday, September 5th will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a yield of 2.80%. The ex-dividend date of this dividend is Wednesday, September 3rd.

A number of analysts have recently weighed in on BAX shares. Analysts at Zacks reiterated a “neutral” rating on shares of Baxter International in a research note on Tuesday. They now have a $79.00 price target on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Baxter International in a research note on Friday, July 18th. They now have a $76.00 price target on the stock, up previously from $75.00.

Baxter International Inc (NYSE:BAX) is a global, diversified healthcare company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.